Skip to main content

Patient-Centered Communication for Discussing Oncotype DX Testing.

Publication ,  Journal Article
Roberts, MC; Bryson, A; Weinberger, M; Dusetzina, SB; Dinan, MA; Reeder-Hayes, KE; Wheeler, SB
Published in: Cancer Invest
May 27, 2016

Oncotype DX testing (ODX), a tumor gene expression test, may improve breast cancer care, however, communicating results remains challenging. We identified patient-centered communication strategies/gaps for discussing ODX results. We applied a patient-centered communication framework to analyze qualitative interviews with oncologists about how they communicate about ODX with patients, using template analysis in Atlas.ti. Overall, providers discussed four patient-centered communication domains: exchanging information, assessing uncertainty, making decisions and cross-cutting themes. Providers did not report discussing emotional aspects of managing uncertainty, assessing decision-making preferences, and evaluating decisions. A patient-centered approach may be a model for communicating about tumor gene expression tests.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Invest

DOI

EISSN

1532-4192

Publication Date

May 27, 2016

Volume

34

Issue

5

Start / End Page

205 / 212

Location

England

Related Subject Headings

  • Uncertainty
  • Sensitivity and Specificity
  • Precision Medicine
  • Patient-Centered Care
  • Oncology & Carcinogenesis
  • Oncologists
  • North Carolina
  • Male
  • Humans
  • Health Communication
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Roberts, M. C., Bryson, A., Weinberger, M., Dusetzina, S. B., Dinan, M. A., Reeder-Hayes, K. E., & Wheeler, S. B. (2016). Patient-Centered Communication for Discussing Oncotype DX Testing. Cancer Invest, 34(5), 205–212. https://doi.org/10.3109/07357907.2016.1172637
Roberts, Megan C., Amy Bryson, Morris Weinberger, Stacie B. Dusetzina, Michaela A. Dinan, Katherine E. Reeder-Hayes, and Stephanie B. Wheeler. “Patient-Centered Communication for Discussing Oncotype DX Testing.Cancer Invest 34, no. 5 (May 27, 2016): 205–12. https://doi.org/10.3109/07357907.2016.1172637.
Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, et al. Patient-Centered Communication for Discussing Oncotype DX Testing. Cancer Invest. 2016 May 27;34(5):205–12.
Roberts, Megan C., et al. “Patient-Centered Communication for Discussing Oncotype DX Testing.Cancer Invest, vol. 34, no. 5, May 2016, pp. 205–12. Pubmed, doi:10.3109/07357907.2016.1172637.
Roberts MC, Bryson A, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Wheeler SB. Patient-Centered Communication for Discussing Oncotype DX Testing. Cancer Invest. 2016 May 27;34(5):205–212.

Published In

Cancer Invest

DOI

EISSN

1532-4192

Publication Date

May 27, 2016

Volume

34

Issue

5

Start / End Page

205 / 212

Location

England

Related Subject Headings

  • Uncertainty
  • Sensitivity and Specificity
  • Precision Medicine
  • Patient-Centered Care
  • Oncology & Carcinogenesis
  • Oncologists
  • North Carolina
  • Male
  • Humans
  • Health Communication